BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 22940241)

  • 1. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 3. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract.
    Mahomed IM; Ojewole JA
    Phytother Res; 2004 Dec; 18(12):982-9. PubMed ID: 15742343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
    Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
    BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
    Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
    Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
    Boje K; Lechtenberg M; Nahrstedt A
    Planta Med; 2003 Sep; 69(9):820-5. PubMed ID: 14598207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
    Abdelouahab N; Heard CM
    Planta Med; 2008 Apr; 74(5):527-31. PubMed ID: 18401847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
    Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)].
    Wegener T
    Wien Med Wochenschr; 1999; 149(8-10):254-7. PubMed ID: 10483693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats.
    Andersen ML; Santos EH; Seabra Mde L; da Silva AA; Tufik S
    J Ethnopharmacol; 2004 Apr; 91(2-3):325-30. PubMed ID: 15120457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS.
    Karioti A; Fani E; Vincieri FF; Bilia AR
    J Pharm Biomed Anal; 2011 Jun; 55(3):479-86. PubMed ID: 21420820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clerodendrum serratum (L.) Moon. - a review on traditional uses, phytochemistry and pharmacological activities.
    Patel JJ; Acharya SR; Acharya NS
    J Ethnopharmacol; 2014 Jun; 154(2):268-85. PubMed ID: 24727551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice.
    Mahomed IM; Ojewole JA
    Brain Res Bull; 2006 Mar; 69(1):57-62. PubMed ID: 16464685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Assessment of Commercial Spagyric Tinctures of
    Avato P; Argentieri MP
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA; Heard CM
    Int J Pharm; 2009 Jul; 376(1-2):63-8. PubMed ID: 19383533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.